US company is attempting to acquire the maker of a new treatment for pancreatic cancer
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn
Recent Posts
- Long-awaited audit reform bill scrapped by UK ministers
- UK set to approve Chinese ‘mega’ embassy after inclusion of security measures
- Bessent questions Europe’s ability to agree strong response to Greenland tariffs
- How to talk Trump down from his Greenland blackmail
- Denmark dispatches additional troops to Greenland as tensions rise
